Japan Hepatitis Diagnostic Market Insight
Published: 01 August 2026 | Report Format: Electronic (PDF) | Author: Govind and Krishna
The Japan Hepatitis Diagnostic Market will grow at a rate of 5.12% due to rising demand for accurate viral screening devices, hospital and clinical laboratory automation, the healthcare sector, and the increasing use of diagnostic assays for screening in healthcare, blood banks, and clinical research.
Japan Hepatitis Diagnostic Market Insights Forecasts to 2035
- The Japan Hepatitis Diagnostic Market Size Was Estimated USD 312.5 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 5.12% from 2025 to 2035
- The Japan Hepatitis Diagnostic Market Size is Expected to rise around USD 514.8 Million by 2035
Notable Insights for the Japan Hepatitis Diagnostic Market
- Segmentation on the basis of Test Type indicates that Immunoassay Diagnostics and high-sensitivity PCR testing kits dominate Japan market in 2025 with 58.4% share across clinical laboratories industry.
- Segmentation on the basis of End User indicates that Hospitals, Diagnostic Laboratories and Blood Screening Centers segment dominates Japan Hepatitis Diagnostic Market 2025 with 61.2% share, driven by routine health screening and viral screening demand.
- World-wide projected revenue of Roche Holding AG in fiscal year 2025 would be around $31.2 billion, owing to high demand for diagnostic testing systems, molecular assays, and healthcare laboratory equipment.
Download the eBook (ToC)
- It is expected that increasing screening programs, routine health checkup needs in clinical care, and adoption of automated assay systems would contribute in driving the growth of the market, where nucleic acid amplification tests offer precise detection up to 98.6%, and minimize diagnostic turnaround times up to 42%.
Why Buy This Report
- Gives an in-depth analysis of the impact of trends in viral biomarker detection, modernization in clinical diagnostic instruments, and development in nucleic acid testing technology on the Japan Hepatitis Diagnostic Market growth.
- Provides strategic insights regarding technology innovation such as chemiluminescence immunoassay technology, PCR-based diagnostic kits, automated blood screening platforms, and real-time viral load monitoring technology.
- Assists players to analyze competitive benchmarking, investment in diagnostic technology, automation in laboratories, and expansion in healthcare facilities by major diagnostic systems suppliers.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan Hepatitis Diagnostic Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in Japan Hepatitis Diagnostic Market
- F. Hoffmann-La Roche Ltd.
- Abbott Laboratories
- Fujirebio Holdings, Inc.
- Sysmex Corporation
- Siemens Healthineers AG
- Bio-Rad Laboratories, Inc.
- Eiken Chemical Co., Ltd.
- Ortho Clinical Diagnostics (QuidelOrtho)
- Thermo Fisher Scientific Inc.
- Hologic, Inc.
Recent Developments:
- In February 2026, Fujirebio Holdings, Inc. introduced high-sensitivity fully automated Hepatitis B core-related antigen (HBcrAg) test reagents integrated with advanced clinical laboratory testing platforms for infection monitoring.
- In November 2025, Sysmex Corporation launched next-generation molecular diagnostic testing systems optimized for rapid Hepatitis C viral RNA quantification requiring high-precision diagnostic accuracy.
Market Segmentation:
Japan Hepatitis Diagnostic Market, By Test Type
- Immunoassay Diagnostics (ELISA, CLIA)
- Molecular Diagnostics (PCR, NAT)
- Rapid Diagnostic Tests (RDTs)
- Point-of-Care Testing (POCT)
- Biochemical & Liver Function Assays
Japan Hepatitis Diagnostic Market, By Technology
- Chemiluminescence Immunoassay (CLIA)
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Microfluidic & Lateral Flow Assays
Japan Hepatitis Diagnostic Market, By End User
- Hospitals & Clinics
- Diagnostic Laboratories & Reference Labs
- Blood Banks & Transfusion Centers
- Academic & Research Institutes
- Ambulatory Healthcare Centers
Expert Views:
The market for hepatitis diagnostics in Japan will grow owing to the rise in the demand for high accuracy diagnostic kits, the growing number of health checkup programs, and increasing demand for molecular diagnostic testing. The inclusion of polymerase chain reaction based screening solutions, chemiluminescence enabled monitoring systems, and automated testing platforms will enhance operational efficiency and boost the demand for hepatitis diagnostics in the Japanese market.
Author: Govind and Krishna By Decisions Advisors and Consulting